Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.

Trinchieri, Vito; Laghi, Luca; Vitali, Beatrice; Parolin, Carola; Giusti, Ilaria; Capobianco, Daniela; Mastromarino, Paola; De Simone, Claudio

Trinchieri, Vito; Laghi, Luca; Vitali, Beatrice; Parolin, Carola; Giusti, Ilaria; Capobianco, Daniela; Mastromarino, Paola; De Simone, Claudio.

Afiliación

Trinchieri V; Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Laghi L; Department of Agricultural and Food Sciences, Interdepartmental Centre for Agri-Food Industrial Research, University of Bologna, Cesena, Italy.
Vitali B; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Parolin C; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Giusti I; Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale S. Tommasi, Coppito, Italy.
Capobianco D; Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Mastromarino P; Department of Public Health and Infectious Disease, Section of Microbiology, Sapienza University Rome, Rome, Italy.
De Simone C; Chateau d'Oex, Switzerland.

Front Immunol ; 8: 1474, 2017.

Article en En | MEDLINE | ID: mdl-29163538

Palabras clave

VSL#3; gut; human immunodeficiency virus; metabolomics; microbiota; probiotics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google